Opinions

Let Them Take Ozempic! People Are Now Using GLP-1s to Save Money on Food

BYKhaoula Ghanem

June 10, 2026

For centuries, hunger was understood as a political failure. When food became too expensive, populations revolted, governments intervened, and economists scrambled to explain why people could no longer afford one of life’s most basic necessities. Hunger was rarely framed as a personal problem because it was widely understood to be a collective one. Today, something stranger is happening: In one of the wealthiest periods in human history, some people are discovering that the easiest way to afford life is to chemically suppress one of the most basic human urges they possess.

As food prices continue to climb across much of the world and household budgets remain under pressure, a growing number of people taking GLP-1 medications are reporting a surprising side effect beyond weight loss. They are spending significantly less money on food. Some users have even described the medications as cheaper than maintaining their previous eating habits.

Drugs such as Ozempic, Wegovy, Mounjaro, and Zepbound mimic hormones naturally produced in the gut after eating. They slow digestion, regulate blood sugar, and send signals to the brain that increase feelings of fullness. Many users report feeling satisfied after eating significantly less food than they once consumed. Others describe a near-total disappearance of what has become known as “food noise,” the constant mental chatter surrounding meals, snacks, cravings, and the anticipation of eating. For people living with obesity and diabetes, these effects can be genuinely life changing. Yet as the drugs have become more widespread, another consequence has emerged. People are spending less money on food because they simply want less of it.

“It’s literally cheaper for me to be on Ozempic than to buy groceries,” wrote X user @Missrobbinbanx.

“My coworker just told me that her Ozempic prescription is cheaper than buying a months worth of groceries now so she just does Ozempic,” user @bustitopen420 shared.

“Thinking of finagling a prescription for Ozempic because with insurance it’s cheaper than the price of groceries now,” quipped journalist Jordan Zakarin.

Taken at face value, the trend might sound like a clever budgeting hack. Look closer, however, and it begins to resemble something much darker. What stage of capitalism are we in when people are willing to accept the cost, inconvenience, and potential side effects of a prescription medication because suppressing appetite has started looking like a rational financial decision?

The numbers are difficult to ignore. A new 2026 survey found that households in the United Kingdom using GLP-1 medications spend an average of £418 less annually on groceries, amounting to an estimated £780 million reduction in grocery spending nationwide. The same research found that many users wanted smaller restaurant portions and even requested dedicated GLP-1-friendly menu sections when dining out.

Similar patterns are emerging in the United States. Research from Cornell University found that households with at least one GLP-1 user reduced grocery spending by roughly 5.3 percent within six months of starting treatment. Spending on snacks, sweets, baked goods, and fast food declined particularly sharply. Meanwhile, restaurant spending also fell.

Modern capitalism depends on appetite. Not merely physical appetite, but endless desire. The system works because consumers are encouraged to want more food, more clothes, more entertainment, more experiences, and more products. Advertising exists to manufacture desire, while entire industries are built around satisfying cravings that often did not previously exist.

GLP-1 drugs interfere with that logic. They reduce hunger, quiet cravings, and weaken what users commonly describe as “food noise.” In many cases, they also appear to reduce impulse purchases and diminish interest in highly processed foods designed to maximize consumption. Researchers and market analysts have increasingly begun discussing how these medications could reshape spending patterns across the food industry. In other words, one of the most profitable industries on earth is confronting a peculiar challenge. What happens when millions of consumers suddenly want less?

The irony is difficult to miss. For decades, food manufacturers spent billions engineering products that encouraged overconsumption. Sugar, salt, fat, texture, packaging, and advertising were carefully calibrated to keep consumers reaching for another bite. Then pharmaceutical companies introduced drugs that suppress the very cravings that food corporations spent decades cultivating.

In his 2009 book Capitalist Realism, British cultural theorist Mark Fisher argued that capitalism had become so dominant that it increasingly presented itself as the only viable way of organizing society. Rather than imagining alternatives, people became preoccupied with adapting themselves to existing conditions. It became easier to manage the symptoms than to question the system producing them.

The growing popularity of GLP-1 medications can be read through that lens. Faced with rising food costs, stagnant wages, and growing economic insecurity, the collective response is not necessarily to demand cheaper food or a different economic arrangement. Instead, the solution increasingly arrives in the form of self-modification. Rather than restructuring the conditions that make food difficult to afford, we restructure the appetite itself.

In many ways, the GLP-1 boom feels like a perfect expression of capitalist realism. It has become easier to imagine chemically suppressing hunger than building an economy in which basic necessities remain comfortably within reach.

Historically, rising food costs were treated as economic failures requiring collective solutions. The French Revolution famously erupted amid soaring bread prices. Bread riots occurred throughout Europe, North Africa, and the Middle East whenever staple foods became inaccessible. Even during the Arab uprisings of 2011, economists pointed to food inflation as one factor contributing to public anger. Today, however, the response often feels different. Instead of demanding cheaper food, some people are learning how to need less of it.

This is neoliberalism at its most intimate. Rather than changing the economic conditions surrounding us, we alter ourselves to better survive them. Unable to reduce housing costs, we take on additional work. Unable to shorten working hours, we optimize productivity. Unable to make food more affordable, we suppress appetite. Perhaps the bleakest aspect of this phenomenon is how quickly the market has adapted.

Restaurants have already begun exploring smaller portions and GLP-1-friendly offerings. Meanwhile, it is hardly a coincidence that protein has become a cultural obsession at precisely the same moment GLP-1 use has exploded. Capitalism possesses a remarkable ability to absorb criticism and transform it into opportunity. First, it creates conditions that encourage overconsumption. Then it sells products designed to counteract overconsumption. Finally, it creates entirely new markets around those products. Nothing illustrates this cycle more clearly than the GLP-1 boom itself.

None of this means GLP-1 medications lack legitimate medical value. For many people living with obesity, diabetes, and related health conditions, these drugs can be genuinely transformative. Their effectiveness is real, and their benefits should not be dismissed. Yet their growing role as a financial strategy deserves closer scrutiny.

A century ago, economists worried about whether people could afford enough food to survive. Today, some consumers are discovering that life becomes more affordable when they stop wanting food altogether. That is not evidence of technological progress, but of a society that increasingly treats human needs as expenses to be managed rather than rights to be fulfilled.

Let Them Take Ozempic! People Are Now Using GLP-1s to Save Money on Food

Suggestions

Articles

Topics

Let Them Take Ozempic! People Are Now Using GLP-1s to Save Money on Food

Related Stories

More From Opinions

Suggestions

Articles

Topics

Newsletter

The only newsletter you won't unsubscribe from

Follow Us